HPAFII细胞
文献支持

HPAFII细胞

收藏
  • ¥1800
  • EK-Bioscience已认证
  • CD-Y1746
  • 2025年07月13日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    HPAF-II/HPAF-II细胞系/HPAF-II细胞株/HPAF-II人胰腺癌细胞

    Cell line name HPAF-II

    Synonyms HPAF II; HPAFII; HPAF-2; HPAF2; HPAF/CD18; CD18/HPAF; HPAF-II/CD18; CD-18; CD18; CD 18

    Accession CVCL_0313

    Resource Identification Initiative To cite this cell line use: HPAF-II (RRID:CVCL_0313)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: KuDOS 95 cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Part of: NCI RAS program mutant KRAS cell line panel.

    Population: Caucasian.

    Doubling time: 26 hours (PubMed=2734279); 70 hours (PubMed=25984343).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: Array-based CGH.

    Omics: CRISPR phenotypic screen.

    Omics: Deep exome analysis.

    Omics: Deep proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Metabolome analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: Proteome analysis by 2D-DE/MS.

    Omics: shRNA library screening.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do.

    Caution: TP53 mutation indicated incorrectly as being at c.452C>T in PubMed=1764370.

    Misspelling: HPAF11; PubMed=25984343.

    Misspelling: Hapaf-II; Note=Occasionally.

    Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.

    PubMed=1764370; DOI=10.1038/bjc.1991.467; PMCID=PMC1977874

    Barton C.M., Staddon S.L., Hughes C.M., Hall P.A., O'Sullivan C., Kloppel G., Theis B., Russell R.C.G., Neoptolemos J., Williamson R.C.N., Lane D.P., Lemoine N.R.

    Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

    Br. J. Cancer 64:1076-1082(1991)

     

    PubMed=11787853; DOI=10.1007/s004280100474

    Moore P.S., Sipos B., Orlandini S., Sorio C., Real F.X., Lemoine N.R., Gress T.M., Bassi C., Kloppel G., Kalthoff H., Ungefroren H., Lohr J.-M., Scarpa A.

    Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

    Virchows Arch. 439:798-802(2001)

     

    PubMed=12068308; DOI=10.1038/nature00766

    Davies H.R., Bignell G.R., Cox C., Stephens P.J., Edkins S., Clegg S., Teague J.W., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.S., Shipley J.M., Hargrave D., Pritchard-Jones K., Maitland N.J., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A.M., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H.F., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

    Mutations of the BRAF gene in human cancer.

    Nature 417:949-954(2002)

     

    PubMed=12692724; DOI=10.1007/s00428-003-0784-4

    Sipos B., Moser S., Kalthoff H., Torok V., Lohr J.-M., Kloppel G.

    A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

    Virchows Arch. 442:444-452(2003)

     

    PubMed=15126341; DOI=10.1158/0008-5472.CAN-03-3159

    Heidenblad M., Schoenmakers E.F.P.M., Jonson T., Gorunova L., Veltman J.A., van Kessel A.G., Hoglund M.

    Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.

    Cancer Res. 64:3052-3059(2004)

     

    PubMed=15367885; DOI=10.1097/00006676-200410000-00004

    Loukopoulos P., Kanetaka K., Takamura M., Shibata T., Sakamoto M., Hirohashi S.

    Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.

    Pancreas 29:193-203(2004)

     

    PubMed=15367897; DOI=10.1097/00006676-200410000-00016

    Rajasekaran S.A., Gopal J., Espineda C., Ryazantsev S., Schneeberger E.E., Rajasekaran A.K.

    HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function.

    Pancreas 29:e77-e83(2004)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    ATCC细胞库
    2025年11月03日询价
    询价
    北京中源合聚生物科技有限公司
    2025年11月17日询价
    ¥1400
    上海盖宁生物科技有限公司
    2025年12月10日询价
    询价
    上海康朗生物科技有限公司
    2025年07月15日询价
    文献支持
    HPAFII细胞
    ¥1800